Atara biotherapeutics announces pricing of $175.5 million public offering

Atara biotherapeutics, inc. (nasdaq:atra), a pioneer in t-cell immunotherapy leveraging its novel allogeneic ebv t-cell platform to develop transforma
ATRA Ratings Summary
ATRA Quant Ranking